Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Filana Therapeutics, Inc.

NASDAQ: FLNA · Life Sciences · 8 alerts · CIK 1069530

Share price
$0.4700Close, Nov 16
Market cap
$23.6M
Shares outstanding
50.27MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Filana Therapeutics, Inc. filings on SEC EDGAR ↗

8:01 AM ET 8-K
Business Update

Filana Therapeutics Business Update

The FDA has lifted a full clinical hold on Filana Therapeutics' IND application for simufilam, allowing the company to proceed with a Phase 2a proof-of-concept study in TSC-related epilepsy. The company expects to begin patient screening by Q1 2027 and has already completed trial-readiness activities including site identification and drug supply preparation.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.